KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) FCF Margin (2016 - 2026)

Fulgent Genetics' FCF Margin history spans 12 years, with the latest figure at 2.66% for Q1 2026.

  • On a quarterly basis, FCF Margin rose 1512.0% to 2.66% in Q1 2026 year-over-year; TTM through Mar 2026 was 47.67%, a 3686.0% decrease, with the full-year FY2025 number at 38.49%, down 3170.0% from a year prior.
  • FCF Margin hit 2.66% in Q1 2026 for Fulgent Genetics, up from 24661.5% in the prior quarter.
  • Over the last five years, FCF Margin for FLGT hit a ceiling of 57.16% in Q1 2022 and a floor of 24661.5% in Q4 2025.
  • Historically, FCF Margin has averaged 1539.66% across 5 years, with a median of 3.82% in 2026.
  • The widest YoY moves for FCF Margin: up 3224bps in 2025, down -2464469bps in 2025.
  • Tracing FLGT's FCF Margin over 5 years: stood at 14.52% in 2022, then grew by 16bps to 16.77% in 2023, then crashed by -200bps to 16.81% in 2024, then plummeted by -146637bps to 24661.5% in 2025, then surged by 100bps to 2.66% in 2026.
  • Business Quant data shows FCF Margin for FLGT at 2.66% in Q1 2026, 24661.5% in Q4 2025, and 13.82% in Q3 2025.